{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3447, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a list of icons to represent key clinical attributes of the drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/9", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-9", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide highlights the clinical need for new therapies due to resistance mutations (G2032R) and CNS involvement.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/10", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-10", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 10, "from": 10, "beatId": "b98b1b24-926a-48e2-9515-38f207bc6589", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The document provides market sizing information for ROS1-positive NSCLC.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The table uses a green background to indicate positive results ('Yes') and white for negative results ('No').", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/11", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-11", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 11, "from": 11, "beatId": "b013e07a-4c63-44dc-ad23-0b79be40daed", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Competition", "beatSlug": "sequoia-pitch-competition", "evidence": "The document presents competitive analysis for NVL-520.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a human anatomy diagram to map specific TRK receptor inhibition side effects to body regions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/12", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-12", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "traction", "function": "show_traction", "notes": "The slide uses dot plots for IC50 data and a bar chart for in vivo efficacy, highlighting NVL-520's performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/13", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-13", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 24, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "2038f58a-de52-4ce2-87cd-b26435c6bd24", "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 1, "objective": "The potential for quick wins with Nuvalent's targeted therapies", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 24, "from": 13, "beatId": "38e371b8-b1f4-4700-814e-96d0791c56bb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "solution", "function": "present_solution", "notes": "The slide uses two distinct chart types to demonstrate efficacy: a bar chart for brain penetrance and a grouped bar chart for selectivity index.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/14", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-14", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 24, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "2038f58a-de52-4ce2-87cd-b26435c6bd24", "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 1, "objective": "The potential for quick wins with Nuvalent's targeted therapies", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 24, "from": 13, "beatId": "38e371b8-b1f4-4700-814e-96d0791c56bb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "appendix_methodology", "function": "present_framework", "notes": "Includes a detailed table of Phase 2 cohorts and a list of study objectives.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/15", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-15", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 24, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "2038f58a-de52-4ce2-87cd-b26435c6bd24", "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 1, "objective": "The potential for quick wins with Nuvalent's targeted therapies", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 24, "from": 13, "beatId": "38e371b8-b1f4-4700-814e-96d0791c56bb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide details the transition from the All-Treated Population (N=35) to the NSCLC Response-Evaluable Population (N=21) through back-fill expansion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/16", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-16", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 24, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "2038f58a-de52-4ce2-87cd-b26435c6bd24", "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 1, "objective": "The potential for quick wins with Nuvalent's targeted therapies", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 24, "from": 13, "beatId": "38e371b8-b1f4-4700-814e-96d0791c56bb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "appendix_data", "function": "analyze_data", "notes": "Data table showing demographics, tumor types, ECOG performance status, and prior treatment history including specific TKI therapies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/17", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-17", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 24, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "2038f58a-de52-4ce2-87cd-b26435c6bd24", "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 1, "objective": "The potential for quick wins with Nuvalent's targeted therapies", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 24, "from": 13, "beatId": "38e371b8-b1f4-4700-814e-96d0791c56bb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix_data", "function": "analyze_data", "notes": "Data as of 13 Sep 22. Table lists specific adverse events by grade.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/18", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-18", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 24, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "2038f58a-de52-4ce2-87cd-b26435c6bd24", "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 1, "objective": "The potential for quick wins with Nuvalent's targeted therapies", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 24, "from": 13, "beatId": "38e371b8-b1f4-4700-814e-96d0791c56bb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "traction", "function": "analyze_data", "notes": "The chart displays dose-dependent exposure levels exceeding multiple target thresholds for ROS1 variants in CNS and periphery.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/19", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-19", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 24, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "2038f58a-de52-4ce2-87cd-b26435c6bd24", "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 1, "objective": "The potential for quick wins with Nuvalent's targeted therapies", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 24, "from": 13, "beatId": "38e371b8-b1f4-4700-814e-96d0791c56bb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "traction", "function": "show_traction", "notes": "Clinical trial data table showing efficacy metrics for a drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/20", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-20", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 24, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "2038f58a-de52-4ce2-87cd-b26435c6bd24", "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 1, "objective": "The potential for quick wins with Nuvalent's targeted therapies", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 24, "from": 13, "beatId": "38e371b8-b1f4-4700-814e-96d0791c56bb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "traction", "function": "show_traction", "notes": "The chart uses a waterfall plot to visualize clinical efficacy, a standard in oncology drug development.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/21", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-21", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 24, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "2038f58a-de52-4ce2-87cd-b26435c6bd24", "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 1, "objective": "The potential for quick wins with Nuvalent's targeted therapies", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 24, "from": 13, "beatId": "38e371b8-b1f4-4700-814e-96d0791c56bb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "traction", "function": "show_traction", "notes": "The chart is a swimmer plot, commonly used in oncology clinical trials to visualize time-to-event data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/22", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-22", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 24, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "2038f58a-de52-4ce2-87cd-b26435c6bd24", "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 1, "objective": "The potential for quick wins with Nuvalent's targeted therapies", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 24, "from": 13, "beatId": "38e371b8-b1f4-4700-814e-96d0791c56bb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "traction", "function": "show_traction", "notes": "Includes clinical trial data (ORR, tumor shrinkage, allele clearance) for a specific drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/23", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-23", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 24, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "2038f58a-de52-4ce2-87cd-b26435c6bd24", "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 1, "objective": "The potential for quick wins with Nuvalent's targeted therapies", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 24, "from": 13, "beatId": "38e371b8-b1f4-4700-814e-96d0791c56bb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "traction", "function": "show_traction", "notes": "Includes MRI scan series showing lesion reduction over 8 weeks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/24", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-24", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 24, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "2038f58a-de52-4ce2-87cd-b26435c6bd24", "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 1, "objective": "The potential for quick wins with Nuvalent's targeted therapies", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 24, "from": 13, "beatId": "38e371b8-b1f4-4700-814e-96d0791c56bb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document showcases preclinical and clinical data for NVL-520 and NVL-655.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "testimonial", "function": "illustrate_case", "notes": "Includes a timeline of treatments leading up to NVL-520 and radiological evidence of response.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/25", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-25", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "key_takeaways", "function": "summarize", "notes": "Clinical trial summary slide for Nuvalent's ARROS-1 study.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/26", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-26", "loopMatches": [ { "to": 26, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fe9c6514-22f1-4979-9b36-391b44fa3c8a", "evidence": "The document presents the limitations of current therapies and the potential benefits of Nuvalent's targeted therapies.", "position": 0, "objective": "The cost of inaction in addressing kinase resistance and selectivity challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a list format to define the TPP, which is a standard pharmaceutical industry framework.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/27", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The table highlights the progression of resistance mutations and the increasing prevalence of CNS disease as patients move through lines of therapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/28", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The table uses a green/white color coding to highlight positive attributes of NVL-655 compared to competitors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/29", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "solution", "function": "present_solution", "notes": "The slide uses three distinct chart types to demonstrate efficacy, pharmacokinetics, and selectivity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/30", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "traction", "function": "show_traction", "notes": "The slide compares vehicle control against NVL-655 treatment in both bar chart (multiple models) and line chart (PDX model) formats.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/31", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "The slide outlines the study design for NVL-655, including dose levels for Phase 1 and specific inclusion criteria for Phase 2 cohorts (2a-2d).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/32", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "product_demo", "function": "present_solution", "notes": "The slide outlines the key therapeutic advantages of the drug candidate NVL-330.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/33", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "solution", "function": "present_solution", "notes": "Includes three distinct charts: a dot plot for IC50, a bar chart for selectivity index, and a bar chart for brain penetrance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/34", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/35", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "other", "function": "present_framework", "notes": "The slide uses a diagonal process flow with hexagonal containers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/36", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-36", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a standard pharmaceutical pipeline visualization format.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/37", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "executive_summary", "function": "summarize", "notes": "Includes a 3D molecular structure visualization.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/38", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-03fc-75b4-9b20-1ad4baba72b2", "docSlug": "9cc11288f450409d9a3eef75fc694943", "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "cover", "function": "front_matter", "notes": "Includes a molecular structure visualization.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-03fc-75b4-9b20-1ad4baba72b2/39", "deckHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2", "deckAnchorHref": "/decks/019de075-03fc-75b4-9b20-1ad4baba72b2#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/bT6QlIOinRaEEd7m4khgqPZB9-FaAl6YcL1KJbqo7IE/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZDA4MWQ0ZjgzZWM2ODliNWY1YmY3MDQxYjE4ZmY2Zi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/1", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/TJ7iv3IfUXsZpfq1b7aeOcruCGbpw5tJPhsOZA59o9Q/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZDA4MWQ0ZjgzZWM2ODliNWY1YmY3MDQxYjE4ZmY2Zi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/ID3Ofd_aCkkMIy_EGhXH4J6_HBE0skaihhP6DmMipNM/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZDA4MWQ0ZjgzZWM2ODliNWY1YmY3MDQxYjE4ZmY2Zi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/qfh1_VcnCiTNraiWSSoQL2FWLApKtHme589porCcqys/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZDA4MWQ0ZjgzZWM2ODliNWY1YmY3MDQxYjE4ZmY2Zi9wMDAxLnBuZw" }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "team_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/2", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "disclaimer", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/3", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "other", "function": "other", "notes": "This is a photograph of a real-world OOH (out-of-home) advertisement, not a standard slide deck page.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/4", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "team_bio", "function": "introduce_nominees", "notes": "The slide uses custom icons (thumbs up for the outgoing CEO, flexed-arm milk cartons for the incoming CEO) to denote leadership attributes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/5", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/6", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 6, "beatId": "769c4947-753f-4a67-b239-36cf4dca927e", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Messages", "beatSlug": null, "evidence": "The presentation starts by highlighting key messages.", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "kpi_overview", "function": "summarize", "notes": "The slide uses pink circles to highlight specific bps and dollar changes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/7", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 7, "beatId": "7fb8de06-d318-461f-bc86-efff284c1ddc", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "KPI Overview", "beatSlug": null, "evidence": "The presentation provides an overview of key performance indicators.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "key_messages", "function": "prioritize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/8", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a three-column layout to present category growth, market share trends, and customer logos.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/9", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-9", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "other", "function": "illustrate_case", "notes": "The slide uses photographic evidence of retail shelf placement and point-of-sale displays to support the thesis of market expansion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/10", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "key_messages", "function": "present_solution", "notes": "The slide uses a visual collage style to showcase OOH advertising and product activations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/11", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a map to illustrate geographic expansion and a bar chart to quantify the impact of new markets on growth.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/12", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "key_messages", "function": "prioritize", "notes": "The slide uses a simple matrix-like layout to categorize strategic initiatives.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/13", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/14", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses three distinct chart types to illustrate commercial progress: bar charts for distribution and promotion, and a waterfall-style bar chart for share trends.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/15", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/16", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "before_after", "function": "expose_contradiction", "notes": "The slide shows the same creative execution applied to two different media formats (billboard and print ad).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/17", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "key_messages", "function": "prioritize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/18", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/19", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/20", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/21", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 21, "beatId": "d6de6064-328f-4964-8098-67c8745276e7", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Executive Summary", "beatSlug": null, "evidence": "The presentation provides an executive summary of the results.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "cover", "function": "front_matter", "notes": "The slide uses a high-contrast, provocative brand image as a background for a financial presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/22", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a typewriter-style font and includes footnotes regarding non-IFRS measures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/23", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "revenue_buildup", "function": "analyze_data", "notes": "The chart uses a waterfall bridge to explain the 18% YoY revenue growth.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/24", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "revenue_buildup", "function": "analyze_data", "notes": "The slide uses a 'Constant Currency' framework to isolate operational growth from currency fluctuations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/25", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "before_after", "function": "analyze_data", "notes": "The chart uses a waterfall-bridge structure to explain the variance in gross margin percentage.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/26", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart displays negative EBITDA values across regions and corporate, with a trend of narrowing losses over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/27", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a process-like flow to connect 2023 targets to a 2024 outcome.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/28", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-04d3-74a8-b82e-e869cf1e6287", "docSlug": "cd081d4f83ec689b5f5bf7041b18ff6f", "documentTitle": "Oatly | Results Presentation Deck | 38 slides", "authorId": "oatly", "authorName": "Oatly", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-04d3-74a8-b82e-e869cf1e6287/29", "deckHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287", "deckAnchorHref": "/decks/019de075-04d3-74a8-b82e-e869cf1e6287#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }